Correlation Between Q2 Holdings and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Q2 Holdings and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Q2 Holdings and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Q2 Holdings and Inhibrx, you can compare the effects of market volatilities on Q2 Holdings and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Q2 Holdings with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Q2 Holdings and Inhibrx.
Diversification Opportunities for Q2 Holdings and Inhibrx
0.41 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between QTWO and Inhibrx is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Q2 Holdings and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Q2 Holdings is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Q2 Holdings are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Q2 Holdings i.e., Q2 Holdings and Inhibrx go up and down completely randomly.
Pair Corralation between Q2 Holdings and Inhibrx
Given the investment horizon of 90 days Q2 Holdings is expected to under-perform the Inhibrx. But the stock apears to be less risky and, when comparing its historical volatility, Q2 Holdings is 1.34 times less risky than Inhibrx. The stock trades about -0.16 of its potential returns per unit of risk. The Inhibrx is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 1,388 in Inhibrx on December 19, 2024 and sell it today you would earn a total of 12.00 from holding Inhibrx or generate 0.86% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Q2 Holdings vs. Inhibrx
Performance |
Timeline |
Q2 Holdings |
Inhibrx |
Q2 Holdings and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Q2 Holdings and Inhibrx
The main advantage of trading using opposite Q2 Holdings and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Q2 Holdings position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Q2 Holdings vs. PROS Holdings | Q2 Holdings vs. Meridianlink | Q2 Holdings vs. Enfusion | Q2 Holdings vs. Paylocity Holdng |
Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |